BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 15990159)

  • 21. Validation of an ultrasensitive and specific immunofluorometric assay for mouse follicle-stimulating hormone.
    Jimenez M; Spaliviero JA; Grootenhuis AJ; Verhagen J; Allan CM; Handelsman DJ
    Biol Reprod; 2005 Jan; 72(1):78-85. PubMed ID: 15342359
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low dose acetylsalicylic acid and shedding of microparticles in vivo in humans.
    Lubsczyk B; Kollars M; Hron G; Kyrle PA; Weltermann A; Gartner V
    Eur J Clin Invest; 2010 Jun; 40(6):477-82. PubMed ID: 20456486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of a sensitive, rapid, biotin-streptavidin based chemiluminescent enzyme immunoassay for human thyroid stimulating hormone.
    Lin Z; Wang X; Li ZJ; Ren SQ; Chen GN; Ying XT; Lin JM
    Talanta; 2008 May; 75(4):965-72. PubMed ID: 18585170
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of in vitro-generated platelet microparticles using a modified flow cytometric strategy.
    Tocchetti EV; Flower RL; Lloyd JV
    Thromb Res; 2001 Jul; 103(1):47-55. PubMed ID: 11434945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Flow cytometric detection of circulating platelet-derived microparticles in healthy adult horses.
    Springer NL; Smith E; Brooks MB; Stokol T
    Am J Vet Res; 2014 Oct; 75(10):879-85. PubMed ID: 25255176
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of activated platelets in canine blood by use of flow cytometry.
    Wills TB; Wardrop KJ; Meyers KM
    Am J Vet Res; 2006 Jan; 67(1):56-63. PubMed ID: 16426212
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel test for microparticles in platelet-rich plasma and platelet concentrates using dynamic light scattering.
    Xu Y; Nakane N; Maurer-Spurej E
    Transfusion; 2011 Feb; 51(2):363-70. PubMed ID: 20723171
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development and validation of a time-resolved fluorometric immunoassay for screening of antichlamydial activity using a genus-specific europium-conjugated antibody.
    Tammela P; Alvesalo J; Riihimäki L; Airenne S; Leinonen M; Hurskainen P; Enkvist K; Vuorela P
    Anal Biochem; 2004 Oct; 333(1):39-48. PubMed ID: 15351278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of platelets and platelet-derived material on the activated partial thromboplastin time (Cephotest) coagulation test.
    Mendelsohn EE; Solum NO; Brosstad F
    Scand J Clin Lab Invest; 2005; 65(4):321-32. PubMed ID: 16076687
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A reliable plasma marker of platelet activation: does it exist?
    Gurney D; Lip GY; Blann AD
    Am J Hematol; 2002 Jun; 70(2):139-44. PubMed ID: 12111787
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimization of a time-resolved immunofluorometric assay for tumor-associated trypsin inhibitor (TATI) using the streptavidin-biotin system.
    Osman S; Turpeinen U; Itkonen O; Stenman UH
    J Immunol Methods; 1993 May; 161(1):97-106. PubMed ID: 8486933
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Detection method for platelet activation markers].
    Satoh K; Yatomi Y; Ozaki Y
    Rinsho Byori; 2002 Aug; 50(8):773-8. PubMed ID: 12373813
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Change of platelet activation markers using flow cytometry in patients with hematology/oncology disorders after transfusion.
    Lim YA; Cho SR; Lee WG; Park JS; Kim SW
    Platelets; 2008 Aug; 19(5):328-34. PubMed ID: 18791938
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human platelets secrete the plasma type of platelet-activating factor acetylhydrolase primarily associated with microparticles.
    Mitsios JV; Vini MP; Stengel D; Ninio E; Tselepis AD
    Arterioscler Thromb Vasc Biol; 2006 Aug; 26(8):1907-13. PubMed ID: 16728656
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of platelet-derived microparticles using flow cytometry and its clinical application.
    Cui W; Ma W; Han Y; Lin Q
    Chin Med Sci J; 2003 Mar; 18(1):26-30. PubMed ID: 12901524
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reactive oxygen species and human platelet GP IIb/IIIa receptor activation.
    Sill JC; Proper JA; Johnson ME; Uhl CB; Katusic ZS
    Platelets; 2007 Dec; 18(8):613-9. PubMed ID: 18041653
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet activation status decreases after menopause.
    Aldrighi JM; Oliveira RL; D'Amico E; Rocha T; Gebara OE; Rosano GM; Ramires JA
    Gynecol Endocrinol; 2005 May; 20(5):249-57. PubMed ID: 16019369
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Storage of buffy-coat-derived platelets in additive solutions at 4 degrees C and 22 degrees C: flow cytometry analysis of platelet glycoprotein expression.
    Sandgren P; Hansson M; Gulliksson H; Shanwell A
    Vox Sang; 2007 Jul; 93(1):27-36. PubMed ID: 17547562
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of individual platelet-derived microparticles, comparing flow cytometry and capillary electrophoresis with laser-induced fluorescence detection.
    Xiong G; Aras O; Shet A; Key NS; Arriaga EA
    Analyst; 2003 Jun; 128(6):581-8. PubMed ID: 12866871
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevated platelet microparticles in stable coronary artery disease are unrelated to disease severity or to indices of inflammation.
    Tan KT; Tayebjee MH; Macfadyen RJ; Lip GY; Blann AD
    Platelets; 2005 Sep; 16(6):368-71. PubMed ID: 16194867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.